Vincent P. Ippolito, EVP & Chief Commercial Officer at Anacor Pharmaceuticals, Inc. (ANAC), sold 1,610 shares at $110.76 ($181K) on 2016-01-04, disclosed to the SEC on 2016-01-05.
Open-market sale of $181k ANAC by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.76 | 100 | $11K | 6.1% |
| 2 | $112.21 | 555 | $62K | 34.4% |
| 3 | $112.21 | 555 | $62K | 34.4% |
| 4 | $113.24 | 200 | $23K | 12.5% |
| 5 | $113.24 | 200 | $23K | 12.5% |
| Total | $112.38 avg | 1,610 |
| $181K |
| 100% |
| Filing → |
| ANAC | SELL | 2015-12-11 | $2.2M | — | Filing → |
| ANAC | SELL | 2015-03-04 | $395K | — | Filing → |
| MRX | SELL | 2011-05-17 | $4.2M | — | Filing → |